It’s time for another new series, this time focusing on Testicular Cancer. In this first episode, we lay the foundation for our future discussions and discuss the basics of Testicular Cancer.
Episode contents:
- What are germ cell tumors?
- What are important tumor markers to monitor for germ cell tumors?
- Seminoma vs. Non-seminoma
- Staging of germ ce ... Show More
Mar 12
Episode 148: Myeloma Series, Pt. 8- Transplant in Multiple Myeloma (2026)
Throughout this series, we have discussed that for eligible patients, the current standard of care is to take patients for autologous stem cell transplant as consolidation for their multiple myeloma. In this reboot episode, we sit down with two incredible hematologists who specia ... Show More
52m 47s
Mar 11
Episode 147: Myeloma Series, Pt. 7 - Transplant Consolidation for Multiple Myeloma (2026)
This week, we discuss the role of the “consolidation” phase of treatment in multiple myeloma, focusing on three key trials: IFM 2009, DETERMINATION, and the MIDAS Trial.Content:- What is the role of autologous stem cell transplant in the management of multiple myeloma? - How did ... Show More
26m 12s
Feb 25
Episode 146: Career Development Series-Choosing Your Ideal Mentor
This week, we are so excited to share the first of our Career Development Series episodes, developed in partnership with The American Society of Hematology , The ASH Trainee Council, and Hematopoiesis! For years, our listeners have reached out to our show asking for guidance to h ... Show More
26m 51s
Feb 2025
143. San Antonio Breast Cancer Symposium 2024 - Part 2
<p>Our second SABCS (San Antonio Breast Cancer Symposium) episode covers everything (else) you need to know from 2024. </p><br><p>In this episode, we dive into the role of trastuzumab deruxtecan in HR +ve, HER2 low cancers, perioperative atezolizumab in tnbc, the use of a novel A ... Show More
20m 57s
Dec 2024
139. Back to Basics - Early HER2 Breast Cancer
<p>Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and t ... Show More
24m 31s
Dec 2024
141. Back to Basics - The role of endocrine therapy in Breast Cancer
<p>Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal impro ... Show More
24m 4s
